Kimio Ushijma

15PUBLICATIONS
152CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMedical ethicsObstetrics and gynaecologyMedical genetics (excl. cancer genetics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Jul 25, 2026
A confirmatory trial of hysterectomy with minimal parametrectomy for stage IB1 cervical cancer involving a tumor diameter of 2 cm or less: a Japan Clinical Oncology Group study (JCOG1101).

|Mar 28, 2025
Diagnostic accuracy and prognostic factors of uterine serous carcinoma in Japanese women: a multi-center study.

Shin Nishio, Kimio Ushijima, Mitsuya Ishikawa

|Feb 01, 2024
Analysis of East Asia subgroup in Study 309/KEYNOTE-775: lenvatinib plus pembrolizumab versus treatment of physician's choice chemotherapy in patients with previously treated advanced or recurrent endometrial cancer.

Kan Yonemori, Keiichi Fujiwara, Kosei Hasegawa

|Apr 14, 2023
Lenvatinib Plus Pembrolizumab in Previously Treated Advanced Endometrial Cancer: Updated Efficacy and Safety From the Randomized Phase III Study 309/KEYNOTE-775.

Vicky Makker, Nicoletta Colombo, Antonio Casado Herráez

|Feb 24, 2023
Dynamics in the expression of programmed death ligand 1 and cluster of differentiation 163 in the tumor microenvironment of uterine cervical cancer: a single-center retrospective study.

Yusaku Miyata, Etsuyo Ogo, Toshi Abe

|Jan 20, 2023
Trends and characteristics of fertility-sparing treatment for atypical endometrial hyperplasia and endometrial cancer in Japan: a survey by the Gynecologic Oncology Committee of the Japan Society of Obstetrics and Gynecology.

Kimio Ushijima, Naotake Tsuda, Wataru Yamagami

Pageof 3

Frequent Collaborators

4 joint publications

Shin Nishio

3 joint publications

Toyomi Satoh

3 joint publications

Hideki Tokunaga

3 joint publications

Kazuhiro Takehara